Health & Safety Industry Today

Detail Survey on Gestational Diabetes Market is Expected to Grow at a CAGR over ~ 7.68% by 2023

Market Research Future published a half-cooked research report on global gestational diabetes market. Gestational Diabetes Market is Expected to Grow at a CAGR over ~ 7.68% from 2017 to 2023
Published 06 February 2018

Diabetes is one of the major health problems across the globe. Diabetes is a metabolic disorder in which there is decrease in the level of insulin which ultimately causes increase in the blood sugar level. Gestational diabetes starts when the body is unable to secrete and use all the insulin needed during pregnancy due to which the glucose builds up in the blood to alarmingly high levels. Global gestational diabetes market is driven because of increasing diabetic population. Moreover, governmental initiatives for research & development, rising demand for the better treatment and changing lifestyle habits have fuelled the growth of the market. Obesity, overweight and smoking increases the possibility of the diabetes. Due to sedentary lifestyle and poor diet, the number of obese population has increased which is also contributed in the growth of the market. On the other hand, lack of awareness and high cost of treatment may responsible for restraining the market.

Sample Report Available at .

Key Players

The major key player for the global gestational diabetes market are Antares Pharma (US), INJEX Pharma AG (Germany), 3M (US), Eli Lilly (US), Biocon (US), Sunpharma (India), Sanofi (France), Novo Nordisk (Denmark), Abbott (US), AstraZeneca (UK), Novartis (Switzerland), Daiichi Sankyo (Japan), Boehringer Ingelheim (Germany), Merck & Co. (US), Pfizer (US), Akros Pharma (US), Amgen (US), Adocia (France), Peptron (South Korea), and Takeda (Japan).

Regional Analysis

The Americas commands the major share of the market owing to the large patient population, strong government support for research & development, and high healthcare spending. According to the America Diabetic Association, 29 million Americans were suffering from diabetes which is 9.3% of total America population, among this nearly 50% of patient are women. Moreover, changing lifestyle and poor diet has fuelled the growth of the market.

Europe has the second leading market in global gestational diabetes market which is followed by Asia Pacific. Asia Pacific is the fastest growing market for gestational diabetes. As per statistics, more than 55% of diabetics in the world live in Asia Pacific region. China and India contribute a major share in the Asia Pacific diabetes drug market due to presence of huge diabetic population. Rapidly increasing diabetic and obese population and development in healthcare sector has created a major market for the gestational diabetes.

The Middle East and Africa contribute the least in the market of global gestational diabetes market. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Africa holds the least share of the global market due to limited availability of medical facilities and poor economic condition. However the growth of the Africa market is high due to presence of opportunities for the development of the market.

Browse complete report at .


The global gestational diabetes market is segmented on the basis of types, administration, treatment, and end users.

On the basis of types, the market is segmented into type A1, type A2, and others.

On the basis of administration, the market is categorized into oral, intravenous, and other.

On the basis of treatment, the market is segmented into monitoring, drug treatment, and non-pharmacological treatment. Monitoring is further segmented into urinary glucose testing, oral glucose tolerance test, and others. Drug treatment is sub-segmented into insulin, sensitizers, SGLT-2 inhibitors, alpha-glucosidase inhibitors, and others

On the basis of end users, the market is segmented into hospitals, retail pharmacy, and other.

Market Research Future
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@Marketresearchfuture.Com

Other Industry News

Ready to start publishing

Sign Up today!